Do you want to read an article? Please log in or register.
Changes in natriuretic peptide levels following patiromer-enabled optimization of medical therapy in heart failure: A post hoc analysis of the DIAMOND study
Heart Failure
Related content
Heart Failure
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure
Eur J Heart Fail
Tomasoni D, Benson L, Gatti P, Villaschi A, Ljungman C, Metra M, Scorza R, Braunschweig F, Melin M, Rosano G, Böhm M, Butler J, Abraham WT, Mullens W, Gadler F, Linde C, Lund LH, Savarese G
doi: 10.1002/ejhf.3719
Heart Failure
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Eur J Heart Fail
Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C
doi: 10.1002/ejhf.3565
Heart Failure
Prognostic Value of Natriuretic Peptide Levels in Heart Failure With Recovered Ejection Fraction
Circ Heart Fail
Kodur N, Gunsalus P, Milinovich A, Dalton JE, Tang WHW
doi: 10.1161/CIRCHEARTFAILURE.125.013386
COMMENTED
Heart Failure
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA(1c) levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Lancet Diabetes Endocrinol
Davies MJ, van der Meer P, Verma S, Patel S, Chinnakondepalli KM, Borlaug BA, Butler J, Kitzman DW, Shah SJ, Harring S, Salsali A, Rasmussen S, von Lewinski D, Abhayaratna W, Petrie MC, Kosiborod MN, STEP-HFpEF Trials Committees and Investigators
doi: 10.1016/S2213-8587(24)00304-8
Heart Failure
Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure: The ARIC Study
JACC Heart Fail
Grant JK, Zhang S, Khan SS, Ozkan B, Blumer V, Nambi V, Echouffo-Tcheugui JB, Pandey A, Blumenthal RS, Ballantyne CM, Selvin E, Matsushita K, Shah A, Coresh J, Ndumele CE
doi: 10.1016/j.jchf.2025.102659
Heart Failure
Real-world use of guideline-directed therapy for heart failure: Insights from the Danish Heart Failure Registry
ESC Heart Fail
Schjødt I, Valentin JB, Johnsen SP, Mols RE, Egstrup K, Løgstrup BB
doi: 10.1002/ehf2.15320
Heart Failure
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry)
ESC Heart Fail
Paolillo S, Basile C, Marzano F, Bruzzese D, Agostoni P, Mattavelli I, Aloisio A, Ameri P, Solimano M, Brunetti ND, Calabrò P, Cesaro A, Cameli M, Mandoli GE, Carluccio E, Belardinelli C, Carugo S, Casalino L, Chiuini E, Cosmi D, Dini FL, Di Santo M, Esposito G, Ferrara F, Fierro MF, Galasso G, Gallo L, Rispoli A, Gargiulo P, Grigioni F, Segreti A, Guarnaccia F, Guarnaccia N, Guerra F, Cicchirillo E, Indolfi C, Larcher M, Lillo A, Metra M, Montisci R, Marchetti MF, Nodari S, Fioretti F, Nardi E, Oliviero U, Palazzuoli A, Patti G, Pepe M, Pacelli F, Perrone Filardi F, Putortì G, Santoro G, Senni M, D'Elia E, Severino P, D'Amato A, Soriano S, Sinagra G, Rossi M, Franzese M, Smaldone G, Zito GB, Perrone Filardi P
doi: 10.1002/ehf2.15172
Heart Failure
Prescription of guideline-directed medical therapy in heart failure: impact on mortality and readmission
ESC Heart Fail
Möckel M, Pudasaini S, Feldmann K, Baberg HT, Levenson B, Malzahn J, Mansky T, Michels G, Günster C, Jeschke E
doi: 10.1002/ehf2.15280
Heart Failure
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials
JACC Heart Fail
Lassen MCH, Ostrominski JW, Claggett BL, Neuen BL, Beldhuis IE, Butt J, Biering-Sørensen T, Desai AS, Lewis EF, Jhund PS, Mc Causland F, Anand IS, Pfeffer MA, Pitt B, Zannad F, Zile MR, McMurray JJV, Solomon SD, Vaduganathan M
doi: 10.1016/j.jchf.2025.03.042